Prof Eggert Stockfleth is a speaker at the SCFSA online Skin Cancer Update

Topic: Topical Therapy for Actinic Keratosis and Basal Cell Carcinoma

Md, Phd

Present

University of Bochum & ESCF

Chair and Director of the Department of Dermatology, Venerology, and Allergology at the University of Bochum and Head of the European Skin Cancer Foundation (ESCF).

Visiting Professor

Loyola University Chicago (USA)
Mayo-Clinic Rochester, NY (USA)
University of Melbourne (Australia)
University Department of Dermatology in Kiel and Berlin (Charité, Germany)

University of Hamburg

visiting professor at German Cancer Center Heidelberg (DKFZ)

Professor Effert Stockfleth History and accolades

Professor Eggert Stockfleth is the Chair and Director of the Department of Dermatology, Venerology, and Allergology at the University of Bochum and Head of the European Skin Cancer Foundation (ESCF).

He trained at the University of Hamburg and worked as visiting professor at German Cancer Center Heidelberg (DKFZ), Loyola University Chicago (USA), Mayo-Clinic Rochester, NY (USA), the University of Melbourne (Australia), University Department of Dermatology in Kiel and Berlin (Charité, Germany).

Professor Stockfleth is a member of several organisations including the European Academy of Dermatology and Oncology, European Dermatology Forum, Federal Association of Organ Transplant Patients, and both the European and American Academies of Dermatology.

He is also involved in teaching including training courses for local and international dermatologists, academic courses with bedside teaching, supervision and support of graduate students in medicine and natural sciences, development of teaching concepts based on evidence and problem-based medicine, and he has presented more than 1000 international and national lectures.

His research activities include project leader for international and national studies, especially in the area of ​​prevention (sun protection) and treatment of skin tumors, and research periods in Chicago, Mexico City, and Sydney, he has more than 300 publications listed in PubMed and has authored 40 book chapters and 10 books.

Inova Pharmaceuticals